BI 1703880 clinical trials

A Study to Test How Different Doses of BI 1703880 in Combination With Ezabenlimab Are Tolerated in People With Different Types of Advanced Cancer (Solid Tumours)

This study looks at new treatments, BI 1703880 and Ezabenlimab, for different advanced cancers in adults when other treatments haven't worked. Doctors want to find a safe dose and see if these new drugs help the body fight cancer.